{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:25:22Z","timestamp":1768706722436,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.lfs.2023.122072","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T05:59:57Z","timestamp":1694411997000},"page":"122072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["G protein-coupled receptor 55 activated by palmitoylethanolamide is associated with the development of nocturia associated with circadian rhythm disorders"],"prefix":"10.1016","volume":"332","author":[{"given":"Tatsuya","family":"Ihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youichi","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Shigetomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Danjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schuichi","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2023.122072_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.10053","article-title":"The standardisation of terminology in nocturia: report from the standardisation sub-committee of the international continence society","volume":"21","author":"van Kerrebroeck","year":"2002","journal-title":"Neurourol.Urodyn."},{"issue":"5","key":"10.1016\/j.lfs.2023.122072_bb0010","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00345-014-1396-0","article-title":"Nocturia: state of the art and critical analysis of current assessment and treatment strategies","volume":"32","author":"Oelke","year":"2014","journal-title":"World J. Urol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122072_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11934-019-0940-2","article-title":"Management strategies for Nocturia","volume":"20","author":"Gordon","year":"2019","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.lfs.2023.122072_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.urology.2019.09.022","article-title":"Management of Nocturia and Nocturnal Polyuria","volume":"133s","author":"Weiss","year":"2019","journal-title":"Urology."},{"key":"10.1016\/j.lfs.2023.122072_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2019.06.014","article-title":"Future considerations in Nocturia and nocturnal polyuria","volume":"133s","author":"Weiss","year":"2019","journal-title":"Urology."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.21873\/anticanres.16182","article-title":"Drugs showing real-world efficacy for Nocturia in patients with bladder storage symptoms","volume":"43","author":"Tsubouchi","year":"2023","journal-title":"Anticancer Res"},{"issue":"12","key":"10.1016\/j.lfs.2023.122072_bb0035","first-page":"1398","article-title":"The economic burden of Nocturia on the U.S. health care system and society: a national health and nutrition examination survey analysis","volume":"25","author":"Jhaveri","year":"2019","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00345-017-2097-2","article-title":"Symptom prevalence, bother, and treatment satisfaction in men with lower urinary tract symptoms in Southeast Asia: a multinational, cross-sectional survey","volume":"36","author":"Ho","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.lfs.2023.122072_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119555","article-title":"Different effects of GsMTx4 on nocturia associated with the circadian clock and Piezo1 expression in mice","volume":"278","author":"Ihara","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0050","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1038\/s41598-022-07096-5","article-title":"Effects of fatty acid metabolites on nocturia","volume":"12","author":"Ihara","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0055","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1038\/s41598-019-46517-w","article-title":"Intermittent restraint stress induces circadian misalignment in the mouse bladder, leading to nocturia","volume":"9","author":"Ihara","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2023.122072_bb0060","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/nau.23400","article-title":"The Circadian expression of Piezo1, TRPV4, Connexin26, and VNUT, associated with the expression levels of the clock genes in mouse primary cultured urothelial cells","volume":"37","author":"Ihara","year":"2018","journal-title":"Neurourol.Urodyn."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168234","article-title":"Clock genes regulate the circadian expression of Piezo1, TRPV4, Connexin26, and VNUT in an ex vivo mouse bladder mucosa","volume":"12","author":"Ihara","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2023.122072_bb0070","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ncomms1812","article-title":"Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm","volume":"3","author":"Negoro","year":"2012","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0075","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/s41598-018-23115-w","article-title":"The oscillation of intracellular Ca(2+) influx associated with the circadian expression of Piezo1 and TRPV4 in the bladder urothelium","volume":"8","author":"Ihara","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2023.122072_bb0080","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/nau.23793","article-title":"The time-dependent variation of ATP release in mouse primary-cultured urothelial cells is regulated by the clock gene","volume":"37","author":"Ihara","year":"2018","journal-title":"Neurourol.Urodyn."},{"issue":"4","key":"10.1016\/j.lfs.2023.122072_bb0085","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/nau.23062","article-title":"The clock mutant mouse is a novel experimental model for nocturia and nocturnal polyuria","volume":"36","author":"Ihara","year":"2017","journal-title":"Neurourol.Urodyn."},{"issue":"5","key":"10.1016\/j.lfs.2023.122072_bb0090","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.euf.2021.12.016","article-title":"The prevalence of nocturnal polyuria in the United States: results from the epidemiology of nocturnal polyuria study","volume":"8","author":"Weiss","year":"2022","journal-title":"Eur. Urol. Focus"},{"issue":"4","key":"10.1016\/j.lfs.2023.122072_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13875","article-title":"Is obstructive sleep apnea a circadian rhythm disorder?","volume":"32","author":"\u0160mon","year":"2023","journal-title":"J. Sleep Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.122072_bb0100","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00125-019-05059-6","article-title":"Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes","volume":"63","author":"Mason","year":"2020","journal-title":"Diabetologia."},{"issue":"10","key":"10.1016\/j.lfs.2023.122072_bb0105","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00345-019-02647-4","article-title":"Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men","volume":"37","author":"Kira","year":"2019","journal-title":"World J. Urol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122072_bb0110","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1530\/JME-16-0253","article-title":"GPR55: a new promising target for metabolism?","volume":"58","author":"Tuduri","year":"2017","journal-title":"J. Mol. Endocrinol."},{"issue":"7","key":"10.1016\/j.lfs.2023.122072_bb0115","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122072_bb0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1017\/S0029665116000288","article-title":"Circadian regulation of lipid metabolism","volume":"75","author":"Gooley","year":"2016","journal-title":"Proc. Nutr. Soc."},{"issue":"1 Suppl","key":"10.1016\/j.lfs.2023.122072_bb0125","first-page":"18s","article-title":"Functional roles of fatty acids and their effects on human health","volume":"39","author":"Calder","year":"2015","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.lfs.2023.122072_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2016.03.033","article-title":"A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation","volume":"782","author":"Esposito","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2023.122072_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejphar.2015.11.035","article-title":"Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats","volume":"769","author":"Paterniti","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41598-017-00824-2","article-title":"P2Y6-deficiency increases micturition frequency and attenuates sustained contractility of the urinary bladder in mice","volume":"7","author":"Kira","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2023.122072_bb0145","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/nau.23400","article-title":"The Circadian expression of Piezo1, TRPV4, Connexin26, and VNUT, associated with the expression levels of the clock genes in mouse primary cultured urothelial cells","volume":"37","author":"Ihara","year":"2018","journal-title":"Neurourol.Urodyn."},{"issue":"5\u20136","key":"10.1016\/j.lfs.2023.122072_bb0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000493490","article-title":"Structure-activity relationship of the GPR55 antagonist, CID16020046","volume":"102","author":"Brown","year":"2018","journal-title":"Pharmacology."},{"key":"10.1016\/j.lfs.2023.122072_bb0155","article-title":"The c-FOS protein Immunohistological detection: a useful tool as a marker of central pathways involved in specific physiological responses in vivo and ex vivo","volume":"110","author":"Perrin-Terrin","year":"2016","journal-title":"J. Visualized Exp."},{"issue":"11","key":"10.1016\/j.lfs.2023.122072_bb0160","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/me.2011-1197","article-title":"Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55","volume":"25","author":"Henstridge","year":"2011","journal-title":"Mol. Endocrinol. (Baltimore, Md)."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0165","first-page":"327","article-title":"Neural control of the lower urinary tract","volume":"5","author":"de Groat","year":"2015","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122072_bb0170","first-page":"735","article-title":"Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells","volume":"117","author":"Mitchell","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2023.122072_bb0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2019.06.039","article-title":"GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier","volume":"414","author":"Leo","year":"2019","journal-title":"Neuroscience."},{"issue":"7","key":"10.1016\/j.lfs.2023.122072_bb0180","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.lfs.2023.122072_bb0185","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41593-018-0204-3","article-title":"Voluntary urination control by brainstem neurons that relax the urethral sphincter","volume":"21","author":"Keller","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.lfs.2023.122072_bb0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fphar.2015.00069","article-title":"The therapeutic potential of orphan GPCRs, GPR35 and GPR55","volume":"6","author":"Shore","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"7366","key":"10.1016\/j.lfs.2023.122072_bb0195","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the beta2 adrenergic receptor-Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0200","first-page":"183","article-title":"The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.advenzreg.2011.09.005","article-title":"Phospholipase C signaling and calcium influx","volume":"52","author":"Putney","year":"2012","journal-title":"Adv. Biol. Regul."},{"issue":"8","key":"10.1016\/j.lfs.2023.122072_bb0210","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/CIRCULATIONAHA.111.064303","article-title":"Coronary vasospasm induced in transgenic mouse with increased phospholipase C-delta1 activity","volume":"125","author":"Shibutani","year":"2012","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.lfs.2023.122072_bb0215","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1152\/physrev.00030.2012","article-title":"Urothelial signaling","volume":"93","author":"Birder","year":"2013","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.phrs.2013.01.010","article-title":"Bradykinin modulates spontaneous nerve growth factor production and stretch-induced ATP release in human urothelium","volume":"70","author":"Ochodnick\u00fd","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2023.122072_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2020.102693","article-title":"Functional atropine sensitive purinergic responses in the healthy rat bladder","volume":"227","author":"Stenqvist","year":"2020","journal-title":"Auton. Neurosci. Basic Clin."},{"issue":"21","key":"10.1016\/j.lfs.2023.122072_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217942","article-title":"The basal pharmacology of palmitoylethanolamide","volume":"21","author":"Rankin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.122072_bb0235","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1074\/jbc.M111.296020","article-title":"Modulation of L-\u03b1-lysophosphatidylinositol\/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids","volume":"287","author":"Anavi-Goffer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2023.122072_bb0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cellsig.2017.05.014","article-title":"Succinate, increased in metabolic syndrome, activates GPR91 receptor signaling in urothelial cells","volume":"37","author":"Mossa","year":"2017","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.lfs.2023.122072_bb0245","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.urology.2008.04.069","article-title":"Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study","volume":"72","author":"Falahatkar","year":"2008","journal-title":"Urology."},{"issue":"2","key":"10.1016\/j.lfs.2023.122072_bb0250","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/nau.23910","article-title":"Novel immediate\/sustained-release formulation of acetaminophen-ibuprofen combination (Paxerol\u00ae) for severe nocturia associated with overactive bladder: a multi-center, randomized, double blinded, placebo-controlled, 4-arm trial","volume":"38","author":"Lee","year":"2019","journal-title":"Neurourol.Urodyn."},{"issue":"5","key":"10.1016\/j.lfs.2023.122072_bb0255","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S1677-5538.IBJU.2013.05.07","article-title":"The effect of combined therapy with tamsulosin hydrochloride and meloxicam in patients with benign prostatic hyperplasia symptoms and impact on nocturia and sleep quality","volume":"39","author":"Gorgel","year":"2013","journal-title":"Int. Braz. J Urol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523007075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523007075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T07:51:28Z","timestamp":1710402688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523007075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":51,"alternative-id":["S0024320523007075"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122072","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G protein-coupled receptor 55 activated by palmitoylethanolamide is associated with the development of nocturia associated with circadian rhythm disorders","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122072"}}